Drug
Vaxchora
Vaxchora: highest development phase Post-Market, developed by Emergent BioSolutions. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| VAXCHORA (Cholera Vaccine, Live, Oral) NCT03220737 | Post-Market | Cholera (Disorder) |
Latest
No recent events.
Follow Vaxchora on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.